Product Development

U.S., U.K. volume bets on AZD1222 come into question with vaccine efficacy data 

As U.K.’s MHRA readies review of AZ’s COVID vaccine, company weighs additional trial

As the U.K.’s MHRA prepares to review AstraZeneca and Oxford’s COVID vaccine, AZ is weighing running an additional trial.

As the U.K. moves to review AZD1222 from AstraZeneca and Oxford, efficacy data from the three front-runner COVID-19 vaccines provides an opportunity to take stock of governments’ bets on which candidates